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Lack of F8 mRNA: a novel mechanism leading to hemophilia A
Osman El-Maarri, Heike Singer, Claudia Klein, Matthias Watzka, Ursula Herbiniaux, Hans H. Brackmann, Jo¨rg Schro¨der, Jochen Graw,
Clemens R. Mu¨ller, Wolfgang Schramm, Rainer Schwaab, Thomas Haaf, Peter Hanfland, and Johannes Oldenburg
Hemophilia A (HA) is caused by partial or
total deficiency of F8 protein activity. In a
small group, about 1.8% of patients with
HA, no mutation is found in the F8 gene.
Among this group, we report here on one
patient with severe HA in whom no mRNA
of the F8 gene was detected. Using 2
common polymorphisms in F8 exon 14,
we were able to show that the same allele
shared by the patient, his mother, and his
sister was not detected by reverse tran-
scription–polymerase chain reaction (RT-
PCR) from total blood mRNA. Skewed
X-chromosome inactivation in both the
mother and the sister was excluded by
studying the methylation profile of the
androgen receptor gene (HUMARA lo-
cus). These findings strongly suggest
that the cause of HA in this patient is
either absence or rapid degradation of
the F8 mRNA, which points to a novel
mechanism leading to HA. (Blood. 2006;
107:2759-2765)
© 2006 by The American Society of Hematology
Introduction
Hemophilia A (HA) (OMIM, 306700) is caused by impaired F8
protein activity, resulting from a broad spectrum of mutations
within the F8 gene (GenBank mRNA accession number, M14113).1
Various point mutations leading to either altered or truncated F8
protein and the 2 major inversion hot spots, intron 22 and intron 1
inversions, have been reported.2,3 Most interestingly, in about 1.8%
(15 of 860) of the HA cases we were unable to detect intron 1 or 22
inversions or point mutations or deletions and insertions, even after
sequencing the whole F8 exons and their flanking intronic se-
quences.4 In such cases in which the coding sequence looks normal
on the DNA level, few reasons could explain the absence or
the decrease in the activity of the corresponding gene product.
The first is an absence of mRNA, which includes the rapid
degradation or even the complete lack of transcription; the
second possibility is an inefficient or failure in translation of
the mRNA or even errors in the secretion process. The third,
which is applicable to the F8 protein, is a rapid or accelerated
clearance from blood as in the case of von Willebrand disease
type 2 Normand.
Therefore, to further investigate the reason for HA in this small
number of patients we have recently analyzed the F8 mRNA,
isolated from total blood, without finding any rearrangements (in
11 unrelated patients).5 However, in one patient with severe HA
that we are reporting here we were unable to detect a reverse
transcription–polymerase chain reaction (RT-PCR) product from
the F8 gene. We followed the segregation of this allele on the DNA
level by 2 exon 14 polymorphisms in the family members, mainly
his mother and his sister; the same allele present in the patient and
his mother was also transmitted to his sister. In all 3 individuals we
were unable to get an RT-PCR product corresponding to this allele.
Our data strongly suggest that the cause of HA in this patient is
either absence or rapid degradation of the F8 mRNA, thus pointing
to a novel mechanism leading to hemophilia A.
Patients, materials, and methods
Patients
The index patient is a 13-year-old boy with severe HA. He was on a
prophylactic treatment regime from his second year of life. No inhibitor has
been reported during more than 1000 exposure days. The very first F8
activity test done at age 8 months prior to F8 substitution was below 1%
(both with a chromogenic assay and a one-stage assay). Sensitivity of both
assays cannot distinguish values between 0% and 1%. Moreover, the time
of 152 minutes in the thromboblastogram (normal, 8-12 minutes) strongly
suggests that there is absolutely no functional active F8 protein. He is the
first hemophiliac in this family. The coding regions of the F8 gene in this
patient were sequenced 3 times by 2 independent centers (the covered
sequence relative to the F8 coding region is summarized in Table S1,
available on the Blood website; see the Supplemental Table link at the top of
the online article); both intron 1 and 22 inversions were also excluded. Both
the mother and the sister are suggested to be carriers because of
significantly reduced FVIII:C of 33% and 42%, respectively, whereas the
VWF:Ag levels were in the normal range (mother, 109%; sister, 139%). The
family gave informed consent to participate in the study in accordance with
the Declaration of Helsinki.
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Table 1. Primers used in this study
Primers 5 to 3 Annealing temperature, °C Product size, bp
PBGD control primers
Outer
PBGD_hum-F acc aag gag ctt gaa cat gc 55 784
PBGD_hum-R gaa aga caa cag cat cat gag
Nested
PBGD-N-F aac atg ccc tgg aga 47 144
PBGD-N-R atg agg gtt ttc ccg
F8 exon 14-15 RT-PCR
Outer
F1 aag ggt gaa ttt aca aag gac gt 52 1867
R1 tga aag tta cca tga tat tat ctt
Nested
F2 aga tgg ttt ttc caa gca gca 54 1731
R2 agc cat cag taa att cct gga a
SNuPE
SN-F8Ex14-1241 gta gaa ggt tca tat ga 28
SN-F8Ex14-1269 cac aca gct cat ttc tc 28
F8B-specific RT-PCR
RT
Ex19-26/4* — — —
Outer
F8B-Ex1-F1 cgt atg caa atc gag ggt ct 52 770
Ex19-26/3* — — —
Nested
F8B-Ex1-F2 gat cca aga ccc tgg gaa g 53 657
Ex23/26-R agt ggc cac cct cag tag ag
F8 promoter region
F8P-F1 gga gtg aca gga ctc gct tt 58 695
F8P-R1 aat cgc aaa agg cac aga aa
F8P-F2 ctc tcc cta ata aac att aac ctg a 58 699
F8P-R2 cac tgc tgc cag tat gag ga
F8P-F3 ggc tgt agg caa gcc att ta 58 688
F8P-R3 cat cag aat gta gcc atg gtg
F8P-F4 gga gcc ctt taa cag tgt gc 58 844
F8P-R4 aga aat ccc agt tcc caa cc
F8P-F5 tga aaa ttt ggt aat ggg gtc t 58 785
F8P-R5 gga tct gtg ggc ttt gag aa
F8P-F6 cct tca aca gaa aat cca gca 58 828
F8P-R6 gca aca aga gcg aga ctc tg
F8P-F7 gta gag gat ctg cgc ggt ag 58 838
F8P-R7 cct atg gtg cca caa aat cc
F8P-F8 gat ggc tct gtt tag caa tgg 58 802
F8P-R8 cac gct gag ctc tgt gat gt
F8 3 untranslated region
F8-3 end-F1 gcg agg cac agg acc tct a 58 481
F8-3 end-R1 tgc ttt gtt cca tgc ttg at
F8-3 end-F2 gga gaa acc tgc atg aaa gc 58 596
F8-3 end-R2 ttg gcc atc aca aat ttc aa
F8-3 end-F3 tga gaa tta tag atg ggg ttc aag a 58 593
F8-3 end-R3 ggc aga tgg aag gag cag ta
F8-3 end-F4 ccg tga ctg aaa act aga gtc c 58 576
F8-3 end-R4 tgg ggt taa ctc ctc tac cg
F8-3 end-F5 tcc tgc ttg acc ctt atc tga 58 689
F8-3 end-R5 ctc cca aag tgc cag gat ta
Methylation analysis
Outer
Bi-F8-PN-F1: ttt aaa att aat aat aaa gta gtt g 48 210
Bi-F8-PN-R1: acc taa cca ccc taa aat atc
Nested
Bi-F8-PN-F2: ggg agg tgt ttt gta tat aga atg a 57 195
Bi-F8-PN-R2: tct cca ata aaa ctc acc caa cct t
SNuPE
SN-F8-P-1: ata aag aag tta gat 28
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RT-PCR
Blood (3 mL) was collected in PAXgene blood RNA tubes (PreAnalytiX,
Hombrechtikon, Switzerland). Total cellular RNA was extracted using the
PAXgene Blood RNA kit according to the manufacturer’s procedure
(PreAnalytiX). RNA analysis by RT-PCR was performed as described
earlier5,6 (Figure 1A). Briefly, for the reverse transcription F8 cDNA was
divided into the following 4 different regions that cover all the splicing
sites: region A, exons 1 to 8; region B, exons 8 to 14; region C, exons 14 to
22; and region D, exons 19 to 26. Reverse transcription was performed in a
20-L total volume, using the Ominiscript reverse transcriptase (Qiagen,
Hilden, Germany) according to the manufacturer’s protocol. An internal
control from the human porphobilinogen deaminase gene (PBGD) (Gen-
Bank accession number, NM_000190) was also included in the RT to
exclude any failure in the RT-PCR that could be due to failure in the RT
reaction; a PBGD-specific PCR was positive from each RT.
To increase the sensitivity of detection we performed the RT amplifica-
tions in 2 rounds of PCR using a nested approach. Each PCR consisted of 35
cycles. For the first PCR we used 5 L (for a total of 50-L PCR reaction)
from the reverse transcription. We divided each of the 4 F8 regions (A-D)
into 2 regions (total of 8 overlapping regions) that were amplified, by a
nested PCR approach, using 5L (in total of 50 L) from the first RT-PCR
as a template. Primer sequences and the conditions for amplifications are
given in Table 1.
Search for informative markers
Informative markers (single nucleotide polymorphisms, SNP) in exon 14 of
the factor VIII gene at codon 1241 (nucleotide 3780, CG) and codon 1269
(nucleotide 3864, CA), which are known to harbor 2 frequent SNPs, were
analyzed by direct sequencing in both the mother and the sister of the index
patient. To obtain an RNA-specific RT-PCR (including these 2 polymor-
phisms) that is not contaminated by genomic DNA we used an outer pair of
primers that amplified part of exon 14 to exon 16, F1/R1 (Figure 1B; Table
1). This was followed by a nested PCR that would increase the yield and the
sensitivity of the RT-PCR, F2/R2 (Figure 1B; Table 1).
Allele quantification
To distinguish the presence of 1 or 2 alleles in the RT-PCR product and to
quantify the amount of different alleles, we used linear amplification using
single nucleotide primer extension assay (SNuPE). In such an assay a
primer whose 3 end is just flanking the polymorphic site is extended by one
of either ddNTPs corresponding to the base changes (ie, ddCTP or ddGTP
for polymorphism at F8 nucleotide 3780). Separation and detection of the
products is done by high performance liquid chromatography (HPLC) as
described by El-Maarri et al7 (Figure 2) (see also Table 1, SIRPH analysis).
X-chromosome inactivation
X-chromosome inactivation test at the human androgen receptor gene
(HUMARA) locus was done as described by Allen et al8 (Figure 3). Briefly,
every DNA sample to be tested was digested with HpaII whose activity is
inhibited by methylation; therefore, it will not cut the inactive (methylated)
X chromosome. In a normal, randomly inactivated X chromosome, about
50% of each X chromosome is active and the other 50% is inactive;
therefore, after digestion with HpaII, both copies of X chromosomes should
still be represented as uncut DNA. The highly polymorphic cag repeats in
the human androgen receptor are a useful polymorphic marker to identify
the 2 X chromosomes. From each case to be tested both digested and
undigested DNA are used separately for amplification using fluorescently
labeled primer (HUMARA-Nor-(6-FAM)-F; Table 1). To separate the 2
alleles, the PCR products were run on an ABI sequencer machine (ABI
Instruments, Foster City, CA); PCR product(s) derived from the undigested
DNA would give 2 bands if the 2 alleles have different numbers of cag
repeats. In the case of normal random X-chromosome inactivation, about
Figure 1. RT-PCR analysis in F8. (A) RT-PCR picture in F8 from both the patient (p;
showing no product) and his mother (m; with positive product). Different RT-PCR
regions of the F8 are indicated by Reg A (exons 1-8), B (exons 8-14), C (exons
14-19), and D (exons 19-26), whereas the nested PCRs are labeled 1 to 8. An internal
control for the success of the reverse transcription, in the PBGD gene, is also shown
(A, bottom panel). The PBGD control primer used for the RT was included in each of
the RT reactions of the F8 gene. The PCRs from the control PBGD gene and the F8
gene were done separately (regions A, B, C, and D correspond to the same regions in
the top part of the figure). (B) A schematic diagram showing the relative positions of
the informative markers in F8 exon 14, a picture of the 1.7 kb (kilobase) RNA-specific
RT-PCR product that covers exon 15 and the polymorphic markers in exon 14 is also
shown. (C) Schematic diagram of the intron 22 region showing the 2 nested genes
F8A and F8B. The position of the primers used for the reverse transcription (Ex
19/26-4) and the 2 subsequent PCRs are also shown (first PCR, F8B-Ex1-F1/Ex
19/26-3; second PCR, F8B-Ex1-F2/Ex 23/26-R). A representative picture of the
RT-PCR product of the F8B is also shown. Primers are listed in Table 1.
Table 1. Primers used in this study (Continued)
Primers 5 to 3 Annealing temperature, °C Product size, bp
HUMARA assay
HUMARA-Nor-F 6-FAM-tcc aga atc tgt tcc aga gcg tgc 60 231
HUMARA-Nor-R ctc tac gat ggg ctt ggg gag aac
F8 mRNA analysis — — —
PBGD indicates porphobilinogen deaminase gene; SNP, single nucleotide polymorphism; SNuPE, single nucleotide primer extension; SIRPH, SNuPE-Ion Pair Reverse
Phase HPLC (high-performance liquid chromatography); and —, as described by El-Maarri et al.5
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50% of each X allele is unmethylated and active; therefore, the same 2
alleles should also be detected after HpaII digestion (Figure 3).
Methylation analysis
Bisulfite treatment of the DNA was done as previously described.9 Briefly,
50 to 100 ng DNA were digested with EcoRI (total volume of 21 L). DNA
was denatured by mixing it with 4 L of 2 M NaOH followed by incubation
at 50°C for 15 minutes. After mixing with hot 2% low-melting agarose, the
DNA-Agarose beads were pipetted in 10 L volumes in ice-cold heavy
mineral oil (Sigma, Steimheim, Germany). After the solidification of the
beads, 500 L of a 2.5 M sodium metabisulfite (Merck, Darmstadt,
Germany) and 125 mM hydroquinone (Sigma) pH 5.0 were added. The
tubes were incubated for 30 minutes on ice then for 3 hours 30 minutes at
50°C in the dark. The beads were washed 4 times in 1  TE (pH 8.0),
treated twice with 0.2 M NaOH for 15 minutes, and washed twice with 1 
TE for 10 minutes each. Prior to PCR amplification, the beads were washed
twice with H2O for 10 minutes each, and melted at 70°C for 10 minutes.
Five microliters of this melted agarose were used in each 50-L PCR
reaction. PCR was performed in 2 rounds of amplification to increase the
specificity for the amplification of fully bisulfite-converted templates.
SIRPH analysis for quantitative methylation
The SNuPE-IP RP HPLC assay (SIRPH) was performed as previously
described.7 Briefly, to remove the unreacted PCR oligonucleotides and
excess of dNTPs, the PCR product(s) were purified using QIAquick gel
extraction kit (Qiagen). The SNuPE reaction was prepared by mixing 100
ng PCR product, 12 pmole SNuPE oligonucleotides, 50 M of each ddCTP
and ddTTP (Amersham, Uppsala, Sweden), 3 units thermosequenase
(Amersham) in a total volume of 20 L. This mixture was then incubated
for 60 cycles as follows: 15 seconds at 92°C, 15 seconds at 30°C, and 15
seconds at 60°C. Then, the product was directly loaded on the dHPLC
machine (Wave; Transgenomics, San Jose, CA) to separate the extended
products and quantitatively measure their corresponding peaks.
Results
Absence of detectable mRNA from the index patient and
monoallelic expression in the mother and the sister
As a result of previous extensive work to identify causative
mutations in patients with HA, a small group of patients (about
1.8%; 15 of 860) was identified as having no detectable DNA
alteration in the F8 coding region.4 In one of these patients we were
unable to detect any RT-PCR product from the F8 mRNA from 3
different RNA preparations. A total of 24 RT-PCRs (8 from each
RNA extraction) failed to give any product corresponding to the F8
mRNA (Figure 1). In contrast to the index patient, we were able to
obtain all 8 RT-PCR products from his mother (his sister was not
investigated except for the exon 14 region).
The absence of the RT-PCR product from this patient led us to
investigate whether the same allele is expressed in the mother and
the sister, which are both likely to be carriers because of their low
FVIII:C values. Therefore, to distinguish the 2 alleles, we looked
for the 2 common polymorphisms in F8 exon 14 region (codons
1241, nucleotide 3780CG, and 1269, nucleotide 3864CA) in
both the mother and the sister. Both were informative with the
mother having alleles CC/GA (allele 1 nt3780-nt3864/allele 2
nt3780-nt3864); the daughter has CA/GA allele combination
(Figure 2). The GA allele is shared by the index patient, his mother,
and his sister. We than looked at the RT-PCR products that cover
these 2 polymorphisms in both the mother and the sister (Figure
1B). We were able to detect only the CC (mother) and CA (sister)
alleles but not the GA allele (Figure 2). This observation would
Figure 2. HPLC chromatograms of the single nucleotide primer extension
product to distinguish the 2 alleles in exon 14 to 15 RT-PCRs. The presence of 2
peaks in the DNA-PCR (C and G at codon 1241 and C and A at codon 1269,
respectively) indicate that this is an informative marker in females. The analysis of the
DNA-PCR product that showed 2 alleles (2 peaks) and the RT-PCR product that
showed the presence of only 1 allele (1 peak) indicate a monoallelic expression.
Figure 3. X-chromosome inactivation patterns at the
HUMARA locus. Two controls of random inactivation (the
presence of both alleles 1r and 2r before and after HpaII
digestion) and skewed inactivation (presence of 2 alleles 1k
and 2k before and 1 allele 2k after HpaII digestion) are
included. The male patient has 1 allele 1p corresponding to
his active X chromosome; the same allele is absent after
HpaII digestion, indicating its normal active status. Two
alleles were detected for the mother (1m and 2m) and the
sister (1s and 2s) before and after HpaII digestion, indicating
a normal random X-Chr inactivation in both. In most of the
diagrams, peaks appear in duplicate, which is the result of
unspecific flanking dATP added by the taq polymerase (for
some of the product) at the 3 end of the PCR product. The
small peaks to the left side of each major peak are a result of
slippage of the taq polymerase during the PCR reaction that
results in amplifications of n-1 of the cag repeats.
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suggest either a monoallelic expression or a rapid degradation of
the GA allele on the mRNA level.
To investigate whether this lack of mRNA in this patient is
specific for the F8 gene or includes a broader region, we looked for
the expression of other neighboring transcripts in the F8 region.
The F8 locus is known to contain 2 nested genes: Factor 8A (F8A)
and Factor 8B (F8B).10,11 The F8B transcript consists of exons 23 to
26 of the F8 gene and additionally has a unique small exon (64 bp)
located in F8 intron 22. A bidirectional promoter is shared with the
F8A gene that is transcribed in the opposite direction to both F8 and
F8B. For the F8B-specific RT-PCR we used a forward primer
located in the first exon of F8B and a reverse primer in exon 26 of
F8, followed by a second PCR with nested primers (Figure 1C). A
clear RT-PCR product corresponding to part of the F8B transcript
was obtained from both the mother and the patient (the sister was
not investigated for this transcript). Moreover, a specific RT-PCR
product was also obtained from HCBP6 (hepatitis C virus core-
binding protein 6; gene bank accession number, AY032594) a
neighboring gene about 5 kb upstream of F8, in both the patient and
the mother (data not shown).
X-chromosome inactivation
The absence of detectable expression of the GA allele in the
lymphocyte-derived RNA in both the mother and the sister could
theoretically also be the result of skewed X-chromosome inactiva-
tion that is leaving only the allele from the active X chromosome to
be actively expressed. However, analysis of the HUMARA locus
proved a normal random X-chromosome inactivation in both the
mother and the sister, demonstrated by the presence of both alleles
before and after HpaII digestion (Figure 3). Therefore, a biased or
skewed X-chromosome inactivation does not explain this observed
monoallelic expression.
Methylation analysis
The promoter region of the F8 gene contains no CpG island.
However, about 5 kb upstream of the transcription starting site a
CpG-rich region was identified (GenBank accession number,
AL645722; nucleotides, 14701-15601). Because high level of
methylation in the gene promoter region is known to be associated
with gene silencing, we investigated the possibility that this region
could be more methylated in the silenced allele (ie, in the patient).
Therefore, the methylation pattern of this region was analyzed
using bisulfite-based DNA treatment followed by SIRPH analysis
as a quantitative approach to determine the level of methylation7,9
(Figure 4). We included for this study the 3 family members plus 13
healthy males and females. The observed level of methylation at
the studied CpG site in the patient was 9%, which falls in the
normal range of healthy male controls, 8% to 13%. Therefore, it is
unlikely that a methylation-related silencing mechanism could
explain this absence of F8 RT-PCR from the patient. The mother
and the sister have 26% and 30%, respectively; healthy female
controls varied between 18% and 25%. The differences between
the male and female group of controls suggest that this region is
subject to some slight differential methylation associated with the
X-Chr inactivation process.
Sequencing of F8 promoter and 3-untranslated regions
To exclude any DNA mutations in either the promoter region or the
3-untranslated region, we sequenced about 3 kb upstream of the
translation starting site and about 2 kb downstream from the stop
codon. Both regions were normal (Table S1).
Integrity of the X chromosome and the F8 promoter region
To exclude also gross chromosomal rearrangements that could
influence the F8 expression because of a position effect we
performed karyotype analysis (G-banding at the 500 band
level); no abnormality was observed (data not shown). More-
over, the integrity of the promoter region was further assessed
by Southern blot analysis using F8 exon 1 as a probe; DNA from
the patient, his mother, his sister, and healthy control subjects
were digested with the following enzymes: EcoRI, BglI, or HpaI
(each separately). This covers a region that extends from 3.3 kb
upstream of exon 1 to 11.6 kb downstream of the same exon. All
samples gave expected band sizes as healthy controls (data
not shown).
Discussion
In the present study, we report on a patient with hemophilia A, in
whom we were unable to detect RT-PCR product specific for the
F8 gene from 3 separate mRNA preparations (from total blood)
and 8 different regions of the F8 gene (Figure 1A). To
investigate whether this finding is specific only for this allele in
the patient’s genetic background we studied his mother and his
sister, both of whom were suggested to be carriers from the
laboratory measurements (mother, FVIII:C 33% and VWF:Ag
109%; sister, FVIII:C 42% and VWF:Ag 139%).
The 2 alleles in both the mother and the sister were distin-
guished by the analysis of 2 known polymorphisms in exon 14 of
the F8 gene, C3780G (codon 1241) and C3864A (codon 1269). The
mother was informative for both SNPs, whereas the sister was
informative for only the C3780G polymorphism (Figures 2,5).
RT-PCR revealed that the same GA allele that was not detected in
the patient was also absent from the RT-PCR products of both the
mother and the sister in 3 different experiments. In a control RNA
sample both the CA and GA alleles were detected by RT-PCR
(Figure 2).
The F8 gene main expression sites are the sinusoidal
endothelial cells and Copper cells in the liver as studied in
mice.12 Therefore, this absence of detectable expression in this
patient could be because the studied mRNA are isolated from
total blood that expresses only low levels of F8. Two reasons
argue against this: (1) in humans an ectopic expression of F8 in
total blood can be detected, and this is widely used to screen for
mutations or rearrangements in the F8 cDNA13-15; (2) the
results obtained in control subjects and the reproducibility and
consistency of the experiments in the patient, his mother, and his
sister should exclude any bias being specific for ectopic
lymphocyte RT-PCR.
Figure 4. Quantitative methylation analysis. The methylation levels obtained at 1
CpG site (nucleotide 14779 in AL645722) in a CpG-rich region 5 kb upstream of the
F8 transcription starting site.
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The absence of detectable expression of the GA allele in the
lymphocyte-derived RNA in both the mother and the sister could
theoretically also be the result of skewed X-chromosome inactiva-
tion that is leaving only the allele from the active X chromosome to
be actively expressed. However, analysis of the HUMARA locus
showed a normal random X-chromosome inactivation in both the
mother and the sister (Figure 3).
Another possibility of our finding could be a local abnormal
“condensed” chromatin structure that would affect the expression
of the F8 gene among other neighboring genes. The F8B transcript,
which is completely nested within the F8 locus, represents a good
candidate to further elucidate this possibility. An RT-PCR product
specific for the F8B transcript could be obtained from the patient
RNA (Figure 1C). Similar results were obtained from HCBP6 locus
located 5 kb upstream of the F8 exon 1. Furthermore, the level of
DNA methylation at a CpG-rich region located about 5 kb upstream
from the transcription start site was not different from male control
subjects (Figure 4), thus further arguing against any global regional
silencing because of epigenetic factors.
A second nested gene in the F8 locus is the F8A (located in a
9.1-kb region called intron 22 homologous region 1; int22h-1)
(GenBank accession number, NM_012151) which is expressed
in antisense direction to F8 and is present in 2 additional copies
some 500 to 580 kb downstream of the F8 gene. Antisense
transcription is suggested to play a role in gene regulation
through the degradation in the sense transcript as observed for
RNA interference. However, a correlation of expression be-
tween sense and antisense is not always observed; Katayama et
al16 studied 15 sense and antisense pairs of expressed genes in
bone marrow–derived macrophages after induction with bacte-
rial lipopolysaccharide (LPS). Seven pairs showed variation in
expression after LPS induction; 3 have coregulation in expres-
sion, 2 reciprocal correlation, and a further 2 showed no
correlation. However, it is unlikely that a misexpression (ie,
overexpression) of antisense F8A mRNA could cause the
silencing of the F8 allele in this patient. Such a down-regulation
because of up-regulation of expression in the F8A should affect
both F8 alleles in the females and not only one allele as we
observed in both the mother and the sister.
Furthermore, we could exclude DNA mutation in the pro-
moter region or the 3-untranslated regions by direct sequencing
of about 3 kb upstream of the translation start site and about 2 kb
downstream of the stop codon. Alternatively, a defect in the
3-untranslated region could be excluded because that F8B gene,
which shares the last F8 4 exons, was normally expressed.
Most autosomal genes are biallelically expressed; however,
some normal monoallelic expressions are known in mammals.
Among these are imprinted genes that are expressed, nonrandomly,
from only maternal or paternal copy, and various random monoal-
lelic expressions in autosomal genes like immunoglobulins, T-cell
receptors, interleukins, odorant receptors, and the protocadherin
genes.17 In addition to these genes, pathologic monoallelic expres-
sion in disease-related genes were also reported.18-20 For example,
congenital hypothyroidism is a recessive disease caused by muta-
tions in thyroid peroxidase (TPO); patients are usually homozy-
gous or compound heterozygous for gene mutations. In some 17%
of the cases there is only one mutated allele; in one of these cases
Fugazzola et al18 showed that the intact allele on the DNA level is
unexpressed and undetectable on the RNA level. The exact
molecular mechanism leading to such absence or decrease in
expression is not known. In the case of F8, because of the X-linked
inheritance of the F8 gene, the absence of mRNA in a single allele
with apparently normal DNA sequence is sufficient to cause
hemophilia A in males. Reasons that could explain the absence of
RT-PCR product from a single allele could be a mutation lying
either deep in one of the large F8 introns that affects the stability or
induces the rapid degradation of the mRNA or a mutation located in
a still unknown control region that enhances in cis the expression of
the gene.
Factors affecting genomewide variation in gene expression over
long distances are known to exist, most of them were found to work
in trans; however, some are also known to work in cis.21 Such
factors are found to act over the long range, because they could be
located in large noncoding DNA regions, called gene deserts,
which eventually make any mutation mechanism that neutralizes
them very difficult to detect.22 An example of such long-range
cis-acting regulator was observed in preaxial polydactyly (PPD), a
common limb malformation in humans, whereby the disruption of
a region that resides about 1 Mb (megabase) away causes the
misexpression of the Sonic Hedgehog (Shh) gene.23 Currently, no
hints are available for the existence of such a cis-acting regulator
that acts on the F8 gene; however, the presence of a long-range
acting element cannot be excluded.
In conclusion we are presenting a unique case of HA, where
we provided strong evidence that the absence of expression of
the F8 and/or the rapid degradation of the F8 mRNA is the cause
of HA. This finding points to a novel mechanism leading to HA;
however, the molecular basis behind this phenomenon is still to
be elucidated.
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Figure 5. Pedigree of the family with a summary of the results. The observed
alleles obtained from genomic DNA or from the RT-PCR products are shown as
vertical lines, labeled with C, A, or G for the corresponding polymorphisms at codons
1241 and 1269 (nucleotides 3780 and 3864, respectively). A given allele that was
present in DNA, but not observed in the RT-PCR product, is indicated by X.
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